JPRN-UMIN000031455已完成1 期
The effectiveness of anti-histamine ointment to nasal ala in the patients with allergic rhinitis and bronchial asthma - The effectiveness of anti-histamine ointment to nasal ala
ational Hospital Organization Disaster Medical Center0 个研究点目标入组 10 人开始时间: 2018年2月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Those who have active dermartologic disorders around the nose. Any changes of medications 4 weeks prior to the enrollment.
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety study of the antihistamine V00114CP 2.5 mg in the treatment of seasonal allergic rhinitis. Randomised, double-blind, three arm parellel group study including placebo and active control arm (levocetirizine 5 mg).The medical condition to be investigated in the study is the seasonall allergic rhinitis. The intendent indication for the product is the treatment of the allergic rhinitis.EUCTR2008-008734-36-SKPIERRE FABRE MEDICAMENT900
撤回
4 期
Systemic antihistamines in the treatment of attention-deficit/hyperactivity disorder (ADHD): a pilot study.allergyADHDattention deficit and hyperactivity disorder1000170810009841NL-OMON42065Medisch Centrum Leeuwarden60
尚未招募
不适用
Antihistamines in the treatment of ADHD and allergy.attention-deficit/hyperactivitydisorder (ADHD), atopy, allergy, eczema, asthma, allergic rhinitisNL-OMON24270Dr. T.W. de VriesMedical Center Leeuwarden PediatricsP.O. BOX 8888901 BR LeeuwardenTel. 058-2863385Fax. 058-2863390e-mail: tjalling.de.vries@znb.nl70
进行中（未招募）
不适用
Efficacy and safety study of the antihistamine V0114CP 2.5mg in the treatment of seasonal allergic rhinitis randomized, double-blind, three arm parallel group study including placebo and active control arm (desloratadine 5 mg) - NDSeasonal allergic rhinitisMedDRA version: 9.1Level: LLTClassification code 10001723Term: Allergic rhinitisEUCTR2008-000133-22-ITPIERRE FABRE MEDICAMENT900
进行中（未招募）
1 期
A study to evaluate safety and efficiency of treatment with histamine and interleukin-2 in chronic myelomonocytic leukemia (CMML)Chronic myelomonocytic leukemiaEUCTR2014-004874-41-SEordic MDS study group15